Boceprevir, Ledipasivir/Sofosbuvir, Simeprevir Sodium, Sofosbuvir, and Telaprevir Use

Project Title Boceprevir, Ledipasivir/Sofosbuvir, Simeprevir Sodium, Sofosbuvir, and Telaprevir Use
Date Posted
Monday, February 5, 2018
Project ID
to16_cap_str_wp014-15
Status
In progress
Deliverables
Mini-Sentinel Summary Table Report: Boceprevir, Telaprevir, Simeprevir Sodium, Sofosbuvir, and Ledipasivir/Sofosbuvir Prevalent Use
Related Links
Sofosbuvir and Amiodarone Use and Bradycardia or Pacemaker Insertion
Description

These reports examine prevalent and incident use of five drug products used in the treatment of hepatitis C in the Mini-Sentinel Distributed Database (MSDD). These results were generated using the Mini-Sentinel Distributed Query Tool. These queries were run against the Dispensing Summary Table and distributed on January 15, 2015 to 14 Data Partners; this report includes information from 14 Data Partners.
Medical Product
boceprevir
ledipasivir/sofosbuvir
simeprevir sodium
sofosbuvir
telaprevir
Health Outcome
hepatitis C
Time Period
2011-2014
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER